ストックスクリーナーアプリを入手
0.50
3.81%
-0.0198
アフターアワーズ：
.50
前日終値:
$0.5198
開ける：
$0.514
24時間の取引高:
547.21K
Relative Volume:
0.38
時価総額：
$1.88M
収益：
$3.29M
当期純損益:
$-3.09M
株価収益率:
-0.4065
EPS:
-1.23
ネットキャッシュフロー:
$-2.46M
1週間 パフォーマンス:
-2.91%
1か月 パフォーマンス:
-22.03%
6か月 パフォーマンス:
-35.53%
1年 パフォーマンス:
-42.38%
1日の値動き範囲:
$0.481
$0.5289
1週間の範囲:
$0.444
$0.6529
52週間の値動き範囲:
$0.444
$1.52
Nanovibronix Inc Stock (NAOV) Company Profile
NAOV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.50 | 1.88M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Nanovibronix Inc (NAOV) 最新ニュース
NanoVibronix stock touches 52-week low at $0.46 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix stock touches 52-week low at $0.46 amid market challenges - Investing.com
NanoVibronix (NASDAQ:NAOV) Enters into Securities Exchange AgreementOn January 7, 2025, NanoVibronix, Inc. filed an 8-K form with the Securities and Exchange Commission, disclosing its recent agreement with an institutional investor. The company en - Defense World
NanoVibronix advances medical device development By Investing.com - Investing.com Canada
NanoVibronix announces exchange agreement with investor By Investing.com - Investing.com
NanoVibronix advances medical device development - Investing.com
NanoVibronix Unveils Next-Gen PainShield and UroShield with Enhanced Therapy Features - StockTitan
Transforming catheter care: NanoVibronix completes successful UroShield US trial - Yahoo Finance
NanoVibronix Announces Completion of Pilot Phase of UroShield® Clinical Study at University of MichiganOn January 6, 2025, NanoVibronix Inc. (NASDAQ: NAOV) revealed the successful conclusion of the initial phase of a Randomized Control Trial study at - Defense World
NanoVibronix Advances UroShield® Trial and Receives Nasdaq Extension - TipRanks
NanoVibronix completes pilot study of UroShield - Mass Device
NanoVibronix “achieves goals” of US trial pilot phase with UroShield - Yahoo Finance
NanoVibronix, Inc. Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan - Marketscreener.com
NanoVibronix's UroShield Completes Key Clinical Trial Phase at University of Michigan - StockTitan
NanoVibronix (NASDAQ: NAOV) Shares Key Insights from Annual Stockholder Meeting - Defense World
NanoVibronix Presents at Annual Stockholders Meeting - TipRanks
NanoVibronix Renews Distribution Agreement with Ultra Pain Products Inc., Secures $12 Million Minimum Purchase Commitment - Defense World
NanoVibronix renews distribution with UPPI through 2029 By Investing.com - Investing.com Nigeria
NanoVibronix renews distribution agreement with Ultra Pain Products - MSN
NanoVibronix renews distribution with UPPI through 2029 - Investing.com India
NanoVibronix, Inc. Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Marketscreener.com
NanoVibronix Secures $12M Distribution Deal for PainShield in Major Non-Opioid Pain Management Partnership - StockTitan
NanoVibronix (STU:56R0) Volatility : 85.95% (As of Dec. 04, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com
NanoVibronix Faces Potential Delisting from Nasdaq Due to Non-Compliance - Defense World
NanoVibronix faces potential Nasdaq delisting - Investing.com
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com Nigeria
NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance
Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com
NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy
NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa
NanoVibronix expands global reach, eyes new markets - Investing.com
NanoVibronix Expands Global Reach with NHS Approval, South African Distribution Deal | NAOV Stock News - StockTitan
A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News
Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
NanoVibronix Forges Potential New Distribution Deal - MPO-mag
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan
NanoVibronix stock hits 52-week low at $0.52 - Investing.com India
NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia
Nanovibronix Inc (NAOV) 財務データ
収益
当期純利益
現金流量
EPS
0.25%
0.57%
大文字化:
|
ボリューム (24 時間):